TOKU-E Talks
Find out what we're talking about
-
Posted on 10.23.20
Impressions from the world’s first conference on Coronavirus- ECCVID 2020
This was my first experience with attending a virtual conference. I was really curious about how it would be arranged, and how the experience would translate to a virtual audience.Navigating the ECCVID 2020 platform was very simple. Afte...
-
Posted on 08.12.20
Use of Cyclosporin A as a potential for coronavirus inhibition for COVID-19 disease
The strategy of repurposing existing compounds to combat the new Coronavirus (SARS-Cov2) that causes COVID-19 is one that is being pursued on a global level. As SARS-CoV-2 is quite similar to SARS-CoV based on the full-length genome pro...
-
Posted on 05.21.20
TOKU-E Talks: Something old, something new: Repurposing compounds against COVID-19
The coronavirus disease 2019 (COVID-19) has spread rapidly into a global pandemic and research is underway to discover compounds that have activity against SARS-CoV2, that belongs to the β genus of Coronaviruses (α and β infect mammals w...
-
Posted on 05.11.20
TOKU-E Talks: In life science news
On a cold day in January, we hosted a reporter from the Bellingham Business Journal at a snowy construction site. But this was not just any old site: This is where our new TOKU-E facility is being built (pictured), which will be twice...